RXST Q3'26 Earnings: revenue estimate is 27.19M USD

What happened

RxSight is scheduled to report Q3'26 results on November 3 after the market closes, at 4:00 PM ET. The revenue estimate is 27.19 million USD, and the earnings per share estimate is (0.31) USD.

Confirmed

Global impact / market context

The revenue estimate of 27.19 million USD is lower than the prior quarter's reported revenue, so the report will show whether sales slowed. Because RxSight has posted negative earnings per share, investors will watch spending and cash use.

Analyst inference

Revenue beat estimates in the last four quarters, and earnings per share beat in three of four. That history raises expectations, so a result below 27.19 million USD could push investors to reassess growth and reposition holdings.

Analyst inference

What to watch

1. The Q3'26 report is due November 3 after the market closes at 4:00 PM ET, and the revenue estimate is 27.19 million USD with an earnings per share estimate of (0.31) USD. Confirmed
2. Watch whether management gives revenue and earnings per share guidance for the next quarter, since forward guidance, which means the company's own forecast, shapes investor expectations. Proposed
3. Compare reported revenue and earnings per share with the 27.19 million USD and (0.31) USD estimates; a miss could pressure the stock, while a beat could support it. Analyst inference

Evidence

• Original source link unavailable